Scholars Central

CommentaryPublished 11 Feb 2025

Optimizing Pharmacotherapy for Atrial Fibrillation and Congestive Heart Failure

Authors: Shradha Bhatnagar

Health Science Journal

Volume 19 · Issue 2 · Pages 1–2

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

This review article explores the crucial elements of medication optimization for two common cardiovascular diseases: Atrial Fibrillation (AF) and Congestive Heart Failure (CHF). AF, characterized by irregular heartbeats, significantly increases the risk of heart failure and stroke. Effective anticoagulation medication is essential for reducing the risk of stroke, alongside rate control and rhythm control measures. The choice of therapy should be tailored to individual patient characteristics. CHF, a complex condition stemming from compromised heart function, is managed with guideline-directed pharmacological therapy, including ACE inhibitors, beta-blockers and diuretics. Recent advancements like Sodium-Glucose Cotransporter 2 (SGLT-2) inhibitors and Angiotensin Receptor Blockers (ARBs) have shown promise in improving patient outcomes.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Health Science Journal.

All its articles

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalHealth Science Journal
  • SubjectGeneral & Internal Medicine
  • BylineArticles whose byline prints “Shradha Bhatnagar”